Prioridad en la atención a niños y niñas en la etapa post covid-19 en Santiago de Cuba.
Posted in Inglés

Cuba has the highest rate of recovered COVID-19 patients in the Americas

With the highest rate of patients recovered from COVID-19 in the Americas -94.2% as of March 20 – and two candidate vaccines in the final stage of clinical trials, Cuba is consolidating its national strategy to confront the pandemic…

Seguir leyendo
La vacuna contra el coronavirus se acerca a las pruebas finales en Cuba
Posted in Inglés

Soberana 02, the first Latin American vaccine in phase III trials

Soberana 02- As the COVID-19 battle continues, the Cuban candidate vaccine becomes the first of its kind in Latin America to reach this stage

Seguir leyendo
La vacuna contra el coronavirus se acerca a las pruebas finales en Cuba
Posted in Inglés

Cuba scales up industrial production of candidate vaccines

Cuba- Industrial production has begun of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19, with progress advancing at BioCubaFarma facilities

Seguir leyendo
Soberana 01, primer candidato vacunal cubano contra la COVID-19 con autorización para ensayos clínicos
Posted in Inglés

Cuba readies 100 million doses of anti-COVID vaccine

Finlay Vaccine Institute director, Dr. Vicente Vérez Bencomo, reports that Cuba is creating capacity to produce 100 million doses of the Soberana 02 vaccine

Seguir leyendo
Vacuna cubana "Soberana", el primer candidato vacunal de América Latina y el Caribe contra la COVID-19. Ilustración: Tomada de Twitter
Posted in Inglés

Soberana 02 clinical trials expanded

Soberana 02 clinical trials expanded. First steps for participating volunteers include signing an informed consent document and evaluation by medical staff

Seguir leyendo